On October 27, the 68th China National Pharmaceutical Machinery Exposition (CIPM) opened at the Xiamen International Conference & Exhibition Center. Pharmaceutical equipment manufacturers and service providers from around the world, together with tens of thousands of industry professionals, gathered in Xiamen for this premier international event dedicated to business collaboration, technology exchange, and industrial innovation.
From technological innovation to commercial application.
From early-stage R&D to large-scale manufacturing.
Morimatsu delivers more professional, efficient, and intelligent end-to-end solutions, empowering every milestone in the pharmaceutical industry's journey of transformation and growth.
1.Connecting Upstream Cell Culture and Downstream Purification: Integrated Laboratory Solutions
Upstream process development is the foundation of biopharmaceutical innovation. Bio-Cruise's upstream solutions include benchtop bioreactors, rocking bioreactors, and single-use bioreactors, providing flexible and reliable support for cell culture, process screening, and scale-up validation.
Downstream processing has a direct impact on product yield, purity, and process robustness. Morimatsu's downstream solutions feature benchtop chromatography systems, tangential flow filtration (TFF), single-use lysis and buffer preparation systems, as well as intelligent microfluidic synthesis platforms, supporting critical processes including purification, concentration, cell lysis, and nanoparticle delivery system development.
2.Unlocking the Value of Flexible Manufacturing:Single-Use Solutions
As demand for flexible manufacturing continues to grow, single-use technologies are becoming an increasingly important direction for the biopharmaceutical industry. Morimatsu's single-use systems support the entire process from R&D through commercial production, accommodating a wide range of applications while providing flexible and efficient manufacturing options.
3.Safeguarding Aseptic Drug Product Manufacturing: Lyophilization System Solutions
Lyophilization plays a critical role in the production of biologics, high-value formulations, and temperature-sensitive products. Built on an integrated functional-unit concept, Senhong's lyophilization solutions offer flexible configurations centered around freeze dryers and supporting systems, enhancing process stability, traceability, and scalability.
4.End-to-End Services for OSD Commercialization:Solid Dosage Process Solutions
The development of solid dosage forms requires highly flexible equipment, adaptable process capabilities, and seamless scale-up pathways. Morimatsu's solid dosage solutions highlight the Mini-WG Wet Granulator and the Mini-MD Multifunctional Fluid Bed System, helping customers improve R&D efficiency and accelerate process optimization.
5.Ensuring Control of Critical API Manufacturing Processes:API Process Solutions
API process development encompasses multiple critical unit operations, including dissolution, crystallization, separation, washing, and drying. Morimatsu's WD Multifunctional Filter Washer Dryer streamlines process workflows, improves manufacturing efficiency, and minimizes contamination risks associated with material transfer.
6.Empowering the Entire Pharmaceutical Manufacturing Lifecycle Through Digitalization:Digital and Intelligent Solutions
To support the industry's digital transformation, Morimatsu's Mo-EAMaster Equipment Management System enables lifecycle-wide digital management, covering procurement, asset registration, maintenance, calibration, validation, and spare parts management, helping ensure compliance and operational reliability throughout pharmaceutical production.
The Bio-Cruise Sterile Automatic Sampling System is designed for material transfer, facility inspections, and manufacturing support applications. By replacing repetitive manual tasks with automated operations, it enhances workshop efficiency while strengthening safety management.
From laboratory research to commercial manufacturing, and from process development to engineering execution, every conversation at the exhibition reflects the vitality of innovation across the pharmaceutical industry. Through continuous engagement with customers and partners, Morimatsu remains committed to advancing its technological expertise and practical innovation capabilities, delivering increasingly comprehensive solutions that support the growth of the life sciences industry and create lasting value.
About Morimatsu LifeSciences
Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Bioengineering AG, Pharmadule Morimatsu AB, and its affiliated companies.
Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.
Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.
Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.
As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.
